Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Phosphorus magnetic resonance spectroscopy monitors muscle energy metabolism by recording the ratio of phosphocreatine to inorganic phosphate at rest, during exercise, and during recovery from exercise. In mitochondrial diseases, abnormalities may appear during some or all these phases. Low phosphocreatine—inorganic phosphate ratios at rest are not disease‐specific, but can be increased by drug therapy in several myopathies. Phosphorus magnetic resonance spectroscopy can also record intracellular pH and thus identify disorders of glycogen metabolism in which the production of lactic acid is blocked during ischemic exercise. The measurements of accumulated sugar phosphate intermediates further delineate glycolytic muscle defects. Myophosphorylase deficiency responds to intravenous glucose administration with improved exercise bioenergetics, but no such response is seen in phosphofructokinase deficiency. The muscular dystrophies show no specific bioenergetic abnormality; however, elevation of phospholipids metabolites and phosphodiesters was detected in some cases. While phosphorus magnetic resonance spectroscopy remains primarily a research tool in metabolic myopathies, it will be clinically useful in identifying new therapies and monitoring their effects in a variety of neuromuscular disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is lower total creatine and PCr content in muscle of IM patients [171,173]”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [173]
In the citing paper
“Another potential benefit of CrM is the replacement of a deficiency state as seen in genetic, inflammatory [172], and mitochondrial [173], myopathies [174].”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [173]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnold, D. L., Matthews, P. M., & Radda, G. K. (1984) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910010303 · Cited by 442
Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy
Arnold, D. L., Taylor, D. J., & Radda, G. K. (1985) · Annals of Neurology · doi:10.1002/ana.410180205 · Cited by 266
EXAMINATION OF A MYOPATHY BY PHOSPHORUS NUCLEAR MAGNETIC RESONANCE
Gadian, D., Ross, B., Bore, P., Radda, G., Hockaday, J., Taylor, D., & Styles, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90186-0 · Cited by 86
Research works printed but not linked: 60
- Taylor DJ, 1983, Bioenergetics of intact human muscle. A gated 31P NMR study, Mol Biol Med, 1, 77
- Radda GK, 1985, Application of nuclear magnetic resonance spectroscopy in pathology, Int Rev Exp Pathol, 2, 1
- 10.1212/WNL.31.7.916 · DOI
- 10.1016/S0022-2828(85)80034-1 · DOI
- Gyulai L, 1985, Bioenergetic studies of mitochondrial oxidative phosphorylation using 31P NMR, J Biol Chem, 260, 3947, 10.1016/S0021-9258(18)89214-6 · DOI · Paper page
- 10.1152/ajpcell.1985.248.3.C279 · DOI · Paper page
- 10.1073/pnas.78.11.6714 · DOI · Paper page
- 10.1073/pnas.82.24.8384 · DOI · Paper page
- Chance B, 1985, Phosphorus nuclear magnetic resonance spectroscopy in vivo, Circulation, 72, 103
- 10.1152/jappl.1989.67.1.324 · doi:10.1152/jappl.1989.67.1.324
- 10.1038/295608a0 · DOI
- 10.1212/WNL.37.2.257 · DOI · Paper page
- Engel AG, 1986, Myology, 1663
- 10.1172/JCI113508 · DOI · Paper page
- 10.1097/00000542-198804000-00006 · doi:10.1097/00000542-198804000-00006
- 10.1007/978-3-642-74415-0_17 · DOI
- 10.1002/mus.880110304 · doi:10.1002/mus.880110304
- 10.1042/bj2290109 · DOI
- 10.1056/NEJM198105283042206 · DOI · Paper page
- 10.1016/S0140-6736(82)92635-6 · DOI · Paper page
- 10.1073/pnas.79.24.7714 · DOI · Paper page
- 10.1212/WNL.37.4.663 · DOI
- 10.1001/archneur.1987.00520180038013 · DOI
- 10.1002/mus.880111210 · DOI
- 10.1002/mus.880090205 · doi:10.1002/mus.880090205
- 10.1007/BF02332211 · doi:10.1007/bf02332211
- 10.1002/ana.410220112 · DOI
- 10.1212/WNL.37.11.1720 · doi:10.1212/wnl.37.11.1720
- 10.1152/jappl.1985.59.6.1991 · doi:10.1152/jappl.1985.59.6.1991
- Rowland LP, 1986, Myology, 1603
- 10.1001/archneur.1965.00470050089010 · doi:10.1001/archneur.1965.00470050089010
- 10.1016/0022-510X(80)90110-0 · doi:10.1016/0022-510x(80)90110-0
- Ruff RL, 1989, Possible role of ADP in contracture of muscle with impaired myoglycolysis, Neurology, 39, 360
- Haller RG, 1988, Glucose impairs exercise performance in muscle phosphofructokinase deficiency: the out of wind effect, Neurology, 38, 270
- 10.1172/JCI112515 · DOI
- 10.1136/bmj.284.6322.1072 · DOI · Paper page
- 10.1212/WNL.37.1.165 · DOI · Paper page
- 10.1002/mus.880080904 · DOI
- 10.1016/0968-0004(85)90070-2 · DOI
- 10.1002/mus.880070605 · DOI
- Bank WJ, 1989, Muscle injury after exercise in canine muscular dystrophy, measured by 31 P NMR, Neurology, 39, 337
- 10.1016/0022-510X(88)90097-4 · DOI
- 10.1016/0047-6374(88)90066-8 · DOI
- 10.1016/S0140-6736(84)91871-3 · DOI · Paper page
- Gross B, 1988, Early acidosis in myalgia and tubular aggregates: 31P magnetic resonance spectroscopy study, Ann Neurol, 24, 165
- 10.1002/mus.880080710 · DOI
- 10.1097/00005373-198908000-00008 · doi:10.1097/00005373-198908000-00008
- 10.1016/0002-9149(88)90266-4 · DOI
- 10.1016/S0002-9149(88)80012-2 · DOI
- 10.1212/WNL.39.6.821 · doi:10.1212/wnl.39.6.821
- 10.1002/mrm.1910070402 · DOI
- 10.1126/science.3726553 · DOI · Paper page
- 10.1073/pnas.81.11.3529 · DOI · Paper page
- 10.1002/ana.410190615 · DOI · Paper page
- Argov Z, 1986, In vivo study of human lipid myopathies by 31P NMR spectroscopy, Ann Neurol, 18, 119
- Heiman‐Patterson TP, 1989, 31P NBMR studies during methylprednisolone treatment of a familial steroid‐responsive mitochondrial disorder, Neurology, 39, 337
- 10.1212/WNL.39.3.399 · DOI · Paper page
- 10.1111/j.1749-6632.1987.tb32934.x · DOI
- 10.1152/ajpcell.1988.254.3.C417 · doi:10.1152/ajpcell.1988.254.3.c417
- Lawson JWR, 1979, Effects of pH and free Mg2+ on the Keq of the creatine reaction and other phosphate hydrolyses and phosphate transfer reaction, J Biol Chem, 254, 6528, 10.1016/S0021-9258(18)50400-2 · DOI · Paper page
Cited by
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
Lodi, R., Cooper, J. M., Bradley, J. L., Manners, D., Styles, P., Taylor, D. J., & Schapira, A. H. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11492 · Cited by 351
Banerjee, B., Sharma, U., Balasubramanian, K., Kalaivani, M., Kalra, V., & Jagannathan, N. R. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.03.008 · Cited by 68
Creatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
Heinänen, Näntö‐Salonen, Komu, Erkintalo, Heinonen, Pulkki, Valtonen, Nikoskelainen, Alanen, & Simell (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00467.x · Cited by 30
Metadata
- Authors
- Argov, Z., & Bank, W. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1991-07
- Volume
- 30
- Issue
- 1
- Pages
- 90-97
- ISSN
- 0364-5134
- 1531-8249
- Cited by
- 89
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. https://app.cochat.ai/papers/10.1002/ana.410300116
- The paper
- Argov, Z., & Bank, W. J. (1991). Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Annals of Neurology. https://doi.org/10.1002/ana.410300116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.